Loading...

GALT GALECTIN THERAPEUTICS INC Other Situations 8-K Filing

GLCT

GLT

GALECTIN THERAPEUTICS INC

(GALT)

2025 8-K

Financial Results

Board Appointment

Retention Bonuses Approved

Director Resignation

Credit Agreement Details

Annual Meeting Results

Annual Meeting Update

Financial Update

Trial Results Announcement

Corporate Update

Financial Update

Compensatory Arrangements o...

Financial Statements

Investor Meetings

Financial Results

Corporate Presentation

Press Release Issued

Annual Meeting Results

Stockholder Meeting

Corporate Presentation

Press Release Issued

Corporate Presentation

Financial Results

Corporate Presentation

Financial Results

Promotion of Dr. Khurram Jamil

Financial Results

Earnings Reports

Annual Meeting of Stockholders

Financial Results

Financial Results Announcement

Earnings Report

Financial Results

Financial Results Announcement

External Links:

On November 10, 2025, Galectin Therapeutics Inc. reported presenting results from its NAVIGATE trial at a major liver diseases conference and updated its corporate presentation on its website. The sentiment of this event is positive, and it is considered significant for the company.

AI Assistant

GALECTIN THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.